Boston, 27th July 2021: Advamedica has raised $6 million in a Series B2 funding round led by TrueScale Capital. Existing investors Omidyar Network, University of California-Ratan N. Tata Fund and Accel also participated in the fundraising.

Advamedica which has now raised a total of more than $20 million, plans to use the fresh capital to build its commercial presence in the United States and the European Union (EU), as well as strengthen its India operations, according to a statement.


Read More